Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coartem Baby safety and clinical response study in infants with uncomplicated malaria
PACTR202609574071161Phase 4Not yet recruiting
- Sponsor
- Novartis
- Start
- Jun 2027
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, single-arm trial of Coartem Baby in malaria and Malaria, sponsored by Novartis. Primary endpoint: Incidence and severity of adverse events and serious adverse events. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
Coartem Baby
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR202609574071161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609574071161.